To date, it has been reported that a small number of proteins, including neurofilament proteins, are differentially expressed in the CSF of ALS and FTD proteins and have been proposed as candidate biomarkers for the C9orf72 mutation [116, 117]. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.